hotspot -WSS

hotspot

author：knowledge 2025-09-28 21:05:40 - browse：4139

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： NIH documents show early flaws of $1.6 billion long Covid program

knowledge

WSS

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Biden praises World Series champion Astros for impact off the field during White House celebration

Germany receives 178 compensation applications from gay servicepeople over discrimination

More regulation could be coming for drug ads

Sage's campaign to raise awareness of postpartum depression hits a nerve

Kaiser's Risant Health gobbled up Geisinger. Who is next?

hotspot

hotspot

focus

ChatGPT in medicine: STAT answers readers' burning questions

Cord blood banking comes at a high cost to babies

What does generative AI mean for health care? We asked experts

NIH documents show early flaws of $1.6 billion long Covid program

23andMe had bad news about my health. I wish a person had delivered it

Sage's campaign to raise awareness of postpartum depression hits a nerve

Moonlake's readout produced a cash windfall. Risks remain

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Cancer drug shortages should be causing more outrage

Zapping the brain for stroke rehab: Pivotal clinical trial begins

focus

The painfully weak evidence on taking collagen to treat arthritis

Zapping the brain for stroke rehab: Pivotal clinical trial begins

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Sage's campaign to raise awareness of postpartum depression hits a nerve

NIH documents show early flaws of $1.6 billion long Covid program

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Wikipedia

hotspot

knowledge

knowledge